Inventor
WAN LIFENG
US14 patents
⚠️ This page may combine multiple inventors who share the name “WAN LIFENG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
13 patentsUS11098051B2Aug 24, 2021
Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections
NOVARTIS AG5 citations82
US10160764B2Dec 25, 2018
Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections
NOVARTIS AG11 citations82
US9694016B2Jul 4, 2017
Biaryl amide compounds as kinase inhibitors
NOVARTIS AG5 citations82
US11453677B2Sep 27, 2022
Tricyclic compounds useful to treat orthomyxovirus infections
NOVARTIS AG2 citations71
US10858366B2Dec 8, 2020
Tricyclic compounds useful to treat orthomyxovirus infections
NOVARTIS AG3 citations71
US8778951B2Jul 15, 2014
Heteroaryl compounds and their uses
NOVARTIS AG4 citations71
US11629149B2Apr 18, 2023
10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1′,2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza
NOVARTIS AG3 citations70
US10709712B2Jul 14, 2020
Biaryl amide compounds as kinase inhibitors
NOVARTIS AG3 citations70
US10245267B2Apr 2, 2019
Biaryl amide compounds as kinase inhibitors
NOVARTIS AG3 citations70
US10167279B2Jan 1, 2019
Compounds and compositions as RAF kinase inhibitors
NOVARTIS AG3 citations69
US11912715B2Feb 27, 2024
Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections
NOVARTIS AG0 citations60
US12071441B2Aug 27, 2024
10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1′,2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza
NOVARTIS AG0 citations59
US10392404B2Aug 27, 2019
Compounds and compositions as kinase inhibitors
NOVARTIS AG0 citations38